ReviewInternational journal of molecular sciences2023

First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations.

Sungpil Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.